FIELD: medicine.
SUBSTANCE: invention relates to compounds selected from a group consisting of compounds listed below or their pharmaceutically acceptable salts that prevent ubiquitinoylation and subsequent destruction of AMP-activated protein kinase (hereinafter – AMPK). The invention also relates to a method for the treatment of a disease or condition selected from sepsis, pneumonia, obesity and diabetes, a method for increasing the amount of phosphorylated AMPK in a cell, and a method for the violation of interaction between Fbxo48 protein and phosphorylated AMPK in a cell using the specified compounds.
EFFECT: obtaining compounds for the treatment of diseases.
,
,
7 cl, 1 tbl, 25 ex, 32 dwg
Title | Year | Author | Number |
---|---|---|---|
ENPP1 INHIBITORS AND METHODS OF MODULATING THE IMMUNE RESPONSE | 2018 |
|
RU2800798C2 |
ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | 2019 |
|
RU2797622C2 |
OPHTHALMIC PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2818087C2 |
COMPOSITIONS AND METHODS OF TREATING DISEASES AND CONDITIONS | 2015 |
|
RU2713886C2 |
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505540C2 |
VET PROTEIN DECOMPOSERS | 2017 |
|
RU2752677C2 |
CFTR REGULATORS AND THEIR APPLICATION METHODS | 2016 |
|
RU2749834C2 |
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505539C2 |
CFTR REGULATORS AND METHODS FOR USE THEREOF | 2016 |
|
RU2742934C2 |
MDM2 PROTEIN DESTRUCTORS | 2017 |
|
RU2743432C2 |
Authors
Dates
2022-02-08—Published
2017-10-04—Filed